Domov › Nazivi delovnih mest › Manager, Regulatory Affairs
Manager, Regulatory Affairs: plače H-1B
72 vlog za delovne pogoje je uporabilo naziv Manager, Regulatory Affairs. Medianna osnovna plača $132.288; srednja polovica $119.706–$144.000.
Vloge (LCA)72
Mediana ponujene plače$132.288
Sredina razpona plač$119.706–$144.000
10.–90. percentil$110.000–$159.500
Ste advokat za priseljevanje, kadrovik ali delodajalec? Predstavite svojo storitev na vrhu te strani — $99 za 30 dni →
Delodajalci
| Delodajalec | LCA | Mediana plače |
|---|
| Edwards Lifesciences LLC | 7 | $132.288 |
| Teva Pharmaceuticals USA, Inc. | 6 | $127.182 |
| ReCor Medical, Inc. | 2 | $150.000 |
| Collegium Pharmaceutical, Inc. | 2 | $158.121 |
| Thermo Fisher Scientific Inc. | 2 | $122.377 |
| Lonza Houston Inc | 2 | $137.511 |
| Becton, Dickinson and Company | 2 | $144.000 |
| Cardinal Health | 2 | $137.002 |
| Eikon Therapeutics, Inc. | 2 | $124.654 |
| Terumo Medical Corporation | 2 | $133.832 |
| Xiromed, LLC | 2 | $125.169 |
| Verastem Inc. | 1 | $133.848 |
| Karyopharm Therapeutics Inc. | 1 | $120.000 |
| Eugia US Manufacturing LLC | 1 | — |
| Emergent Travel Health Inc. | 1 | $136.490 |
| Amarin Pharma Inc. | 1 | $175.000 |
| Bavarian Nordic Inc. | 1 | $134.430 |
| Daiichi Sankyo, Inc. | 1 | $135.000 |
| BeiGene USA, Inc. | 1 | $130.000 |
| McKesson Corporation | 1 | $129.377 |
| Baxter Healthcare Corporation (USA) | 1 | $110.000 |
| Chanel, Inc. | 1 | $110.000 |
| Masimo Corporation | 1 | $127.192 |
| Alvogen Group Inc. | 1 | $142.000 |
| Alnylam US, Inc. | 1 | $140.000 |
| Emergent Product Development Gaithersburg Inc. | 1 | $140.000 |
| Cosette Pharmaceuticals, Inc. | 1 | $85.000 |
| Zydus Pharmaceuticals USA, Inc. | 1 | $112.000 |
| iRhythm Technologies, Inc. | 1 | $187.959 |
| Riconpharma, LLC | 1 | $125.000 |
| Gilead Sciences, Inc. | 1 | $157.991 |
| Helen of Troy Nevada Corporation | 1 | $115.000 |
| Hikma Pharmaceuticals USA Inc. | 1 | $120.453 |
| Bausch Health US, LLC | 1 | $112.235 |
| Apellis Pharmaceuticals Inc. | 1 | $148.384 |
| ChemWerth Inc. | 1 | $113.443 |
| FUJIFILM Sonosite, Inc. | 1 | $137.898 |
| Relay Therapeutics, Inc. | 1 | $100.000 |
| Penumbra, Inc. | 1 | $123.469 |
| Alphatec Spine Inc. | 1 | $150.000 |
| Gen-Probe Incorporated | 1 | $114.691 |
| Syner-G BioPharma Group LLC | 1 | $122.926 |
| Eugia US LLC | 1 | $124.000 |
| AdvaGen Pharma, Ltd. | 1 | $145.000 |
| Synaptic Medical Corp. | 1 | $180.000 |
| Intuitive Surgical Operations, Inc. | 1 | $213.428 |
| CRISPR Therapeutics, Inc. | 1 | $1.524.000 |
| St. Jude Medical, Cardiology Division, Inc. | 1 | $155.000 |
| Revolution Medicines, Inc. | 1 | $159.500 |
| Navinta III Inc. | 1 | $90.000 |
| Aveva Drug Delivery Systems, Inc. | 1 | $110.000 |
| West Pharmaceutical Services, Inc. | 1 | $119.350 |
Po plačilnem razredu
| Raven plače | Mediana plače |
|---|
| Stopnja I (začetna) | $124.004 |
| Stopnja II (kvalificirana) | $134.430 |
| Stopnja III (izkušena) | $136.000 |
| Stopnja IV (polno usposobljena) | $126.672 |
Department of Labor določi štiri stopnje prevladujočih plač za vsak poklic in območje, od Stopnje I (začetna) do Stopnje IV (popolna usposobljenost). Delodajalec izbere stopnjo, ki ustreza zahtevam delovnega mesta.
Po fiskalnem letu
| Poslovno leto | LCA | Mediana plače |
|---|
| Fy2023 | 16 | $133.865 |
| Fy2024 | 18 | $128.148 |
| Fy2025 | 25 | $132.288 |
| Fy2026 | 12 | $135.532 |
Mesta
- Irvine, CA8
- East Windsor, NJ3
- Parsippany, NJ3
- Palo Alto, CA2
- Redwood City, CA2
- Bridgewater, NJ2
- Stoughton, MA2
- San Diego, CA2
- Houston, TX2
- Santa Ana, CA2
- Dublin, OH2
- Cambridge, MA2
- Somerset, NJ2
- West Chester, PA2
- Carlsbad, CA2
- Florham Park, NJ2
- Needham, MA1
- Newton, MA1
- Rochester, NY1
- Basking Ridge, NJ1
- Emeryville, CA1
- Irving, TX1
- Thousand Oaks, CA1
- Piscataway, NJ1
- New York, NY1
- Arlington Heights, IL1
- Gaithersburg, MD1
- South Plainfield, NJ1
- Pennington, NJ1
- San Francisco, CA1
Plače so spodnja meja ponujene plače pri vsaki vlogi, pretvorjene v letni znesek; statistika uporablja samo potrjene vloge za polni delovni čas. LCA ni odobritev vizuma, ena LCA pa lahko pokriva več delovnih mest. Vir: U.S. Department of Labor, OFLC LCA Disclosure Data, davčna leta 2023–2026 (najnovejša odločitev 30. jun. 2026).